Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants
Background: Invasive fungal infection is an important cause of mortality and morbidity in very low birth weight infants. Early diagnosis is difficult, and treatment is often delayed. The available data are insufficient to conclude that topical/oral prophylaxis (usually nystatin and/or miconazole) prevents invasive fungal infection or mortality in very low birth weight infants. Systemic antifungal agents (usually azoles) are increasingly used as prophylaxis against invasive fungal infection....[Show more]
|Collections||ANU Research Publications|
|Source:||Cochrane Database of Systematic Reviews (CDSR)|
|01_Clerihew_Prophylactic_systemic_2007.pdf||201.52 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.